- Home
- HEQ vs OVID Comparison
HEQ vs OVID Comparison
Compare HEQ & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEQ
- OVID
- Stock Information
- Founded
- HEQ 2011
- OVID 2014
- Country
- HEQ United States
- OVID United States
- Employees
- HEQ N/A
- OVID N/A
- Industry
- HEQ Investment Managers
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- HEQ Finance
- OVID Health Care
- Exchange
- HEQ Nasdaq
- OVID Nasdaq
- Market Cap
- HEQ 128.4M
- OVID 117.3M
- IPO Year
- HEQ N/A
- OVID 2017
- Fundamental
- Price
- HEQ $10.66
- OVID $1.32
- Analyst Decision
- HEQ
- OVID Strong Buy
- Analyst Count
- HEQ 0
- OVID 4
- Target Price
- HEQ N/A
- OVID $3.13
- AVG Volume (30 Days)
- HEQ 43.1K
- OVID 1.7M
- Earning Date
- HEQ 01-01-0001
- OVID 11-13-2025
- Dividend Yield
- HEQ 9.78%
- OVID N/A
- EPS Growth
- HEQ N/A
- OVID N/A
- EPS
- HEQ N/A
- OVID N/A
- Revenue
- HEQ N/A
- OVID $6,651,000.00
- Revenue This Year
- HEQ N/A
- OVID $1,081.80
- Revenue Next Year
- HEQ N/A
- OVID N/A
- P/E Ratio
- HEQ N/A
- OVID N/A
- Revenue Growth
- HEQ N/A
- OVID 1070.95
- 52 Week Low
- HEQ $9.08
- OVID $0.24
- 52 Week High
- HEQ $11.84
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- HEQ 47.17
- OVID 41.52
- Support Level
- HEQ $10.58
- OVID $1.27
- Resistance Level
- HEQ $10.79
- OVID $1.44
- Average True Range (ATR)
- HEQ 0.11
- OVID 0.10
- MACD
- HEQ -0.01
- OVID -0.04
- Stochastic Oscillator
- HEQ 24.14
- OVID 14.29
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.